About Holy Cross Medical Group
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Duke University
2
Eisai Inc.
1
Clinical Trials at Holy Cross Medical Group
During the past decade, Holy Cross Medical Group conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Guiding Evidence Based Therapy Using Biomarker Intensified Treatment
2012-12-01
2016-09-20
Terminated
894
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
2014-01-24
2018-05-14
Completed
14,673
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
2016-02-01
2018-05-31
Completed
251
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Holy Cross Medical Group"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Holy Cross Medical Group
According to Clinical.Site data, the most researched conditions in "Holy Cross Medical Group" are
"Atrial Fibrillation" (1 trials), "Cardiovascular Disease" (1 trials), "Heart Failure" (1 trials), "High Cardiovascular Risk" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Holy Cross Medical Group" in a lesser frequency.
Clinical Trials Intervention Types at Holy Cross Medical Group
Most popular intervention types in "Holy Cross Medical Group" are "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Biomarker-guided care NT-proBNP" (1 trials), "Lorcaserin hydrochloride" (1 trials), "Placebo" (1 trials) and "Usual Care" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Holy Cross Medical Group
The vast majority of trials in "Holy Cross Medical Group" are
3 trials for "All" genders.
Clinical Trials Status at Holy Cross Medical Group
Currently, there are NaN active trials in "Holy Cross Medical Group".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Holy Cross Medical Group,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Holy Cross Medical Group, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".